Nuclear Medicine Market 2018 | Emerging Trends | Key Players
Radiopharmaceuticals is a medical specialty that uses specific radiotracers, and have emerged as an efficient imaging technology in the field of nuclear medicine. The non-invasive nature of radiopharmaceuticals has quickened the diagnosis of various diseases such as cardiovascular diseases, neurological disorders, and cancers.
Radiopharmaceuticals is a medical specialty that uses specific radiotracers, and have emerged as an efficient imaging technology in the field of nuclear medicine. The non-invasive nature of radiopharmaceuticals has quickened the diagnosis of various diseases such as cardiovascular diseases, neurological disorders, and cancers.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Nuclear</strong> <strong>Medicine</strong> <strong>Market</strong><br />
Global Opportunity Analysis and Industry<br />
Forecast, 2014 - 2022
Introduction<br />
• Global <strong>Nuclear</strong> <strong>Medicine</strong> <strong>Market</strong> is expected to garner $8,207.5 million<br />
by 2022. The market is currently in its growth stage driven by increasing<br />
number of cancer cases and rising awareness about nuclear medicine.<br />
Radiopharmaceuticals are pharmaceutical formulations comprising<br />
radioactive isotopes that are used in diagnosis and therapeutics. They<br />
are simple and small substances that contain a radioactive substance<br />
that is used in the treatment of cancer and cardiac & neurological<br />
disorders.<br />
• The conventional chemotherapy methods are being replaced by more<br />
convenient therapeutic radiopharmaceuticals for oncology and cancer<br />
treatment, which opens up new avenues in the radiopharmaceuticals<br />
market. Moreover, it not only helps physicians during diagnosis, but also<br />
works as a convenient and safer alternative for patients as compared to<br />
X-Rays and other external radiation imaging devices.
<strong>Nuclear</strong> <strong>Medicine</strong> <strong>Market</strong><br />
Scope of the Report<br />
<strong>Key</strong> Benefits<br />
<strong>Key</strong> Audiences
<strong>Key</strong> Benefits<br />
• This report provides an extensive analysis of the current and emerging<br />
market trends and dynamics in the global nuclear medicine market.<br />
• This report includes a detailed quantitative analysis of the current market<br />
and estimations from 2014 to 2022, which contribute in identifying the key<br />
market opportunities for growth.<br />
• Exhaustive analysis of the global radiopharmaceuticals market by type<br />
helps in understanding the types of radiopharmaceuticals that are currently<br />
being used along with the variants that would gain prominence in the future.<br />
• Competitive intelligence (of leading manufacturers of radiopharmaceuticals)<br />
helps in understanding the competitive scenario across the geographies.<br />
• <strong>Key</strong> market players within the radiopharmaceuticals market are profiled in<br />
this report and their strategies are analyzed thoroughly. This helps in<br />
understanding the competitive outlook of the global nuclear medicine<br />
market.
Table of Content (TOC)<br />
Chapter: 1 Introduction<br />
Chapter: 2 Executive Summary<br />
Chapter: 3 <strong>Market</strong> Overview<br />
Chapter: 4 World Radiopharmaceuticals <strong>Market</strong>, By Type, 2014-2022<br />
Chapter: 5 World Radiopharmaceuticals <strong>Market</strong>, By Modality, 2014-2022<br />
Chapter: 6 World Radiopharmaceuticals <strong>Market</strong>, By Application, 2014-2022<br />
Chapter: 7 World Radiopharmaceuticals <strong>Market</strong>, By End-user, 2014-2022<br />
Chapter: 8 World Radiopharmaceuticals <strong>Market</strong>, By Geography, 2014-2022<br />
Chapter: 9 Company Profiles
Segments<br />
Type<br />
• Diagnostic<br />
• Therapeutic<br />
Modality<br />
• SPECT<br />
• PET<br />
• Alpha-emitters<br />
• Beta-emitters<br />
• Brachytherapy<br />
Segments<br />
Application<br />
• Oncology<br />
• Cardiology<br />
• Neurology<br />
• Thyroid<br />
Procedures<br />
• Oncology<br />
• Cardiovascular<br />
• Central Nervous System<br />
• Endocrine<br />
• Skeletal<br />
• Gastrointestinal
Segments
Analyst Review<br />
• Radiopharmaceuticals is a medical specialty that uses specific radiotracers, and<br />
have emerged as an efficient imaging technology in the field of nuclear medicine.<br />
The non-invasive nature of radiopharmaceuticals has quickened the diagnosis of<br />
various diseases such as cardiovascular diseases, neurological disorders, and<br />
cancers. Nowadays, therapeutic radiopharmaceuticals are preferred to conventional<br />
therapeutic modalities, such as chemotherapy, in the field of oncology for treating<br />
cancers. Radiopharmaceuticals are mostly used in diagnostic applications due to<br />
advancements in the field such as hybrid imaging technologies using PET/CT and<br />
SPECT/CT.<br />
• Convenient therapeutic radiopharmaceuticals procedures have a higher capability of<br />
mapping physiological functions and metabolic activities and providing specific<br />
information about organ function and dysfunction as compared to conventional<br />
imaging modalities such as magnetic resonance imaging (MRI), computed<br />
tomography (CT), and ultrasonography (US) among others. Furthermore, increase in<br />
incidence of cancer & cardiovascular aliments, growing demand for alpha radio<br />
immunotherapy-based targeted cancer treatment, need for nuclear imaging<br />
techniques, and advancements in radiotracers have opened new avenues for<br />
radiopharmaceutical manufactures.
Company Profiles<br />
• Mallinckrodt plc.<br />
• General Electric Co.<br />
• Medtronic, plc. (Covidien, acquired by Medtronic)<br />
• Bayer AG<br />
• Cardinal Health, Inc.<br />
• Lantheus Medical Imaging, Inc.
Thank You<br />
ThankYou!<br />
For More Details<br />
Do Enquiry<br />
https://www.alliedmarketresearch.com/nuclear-medicine-radiopharmaceuticals-market<br />
Follow Us On
Change language